Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease-Reference-Cited by-同舟云学术

Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease

Published:2017-09-26 Issue:9 Volume:12 Page:e0185033
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Olivera Mario J.^ORCID,Cucunubá Zulma M.,Valencia-Hernández Carlos A.,Herazo Rafael,Agreda-Rudenko Diana,Flórez Carolina,Duque Sofía,Nicholls Rubén S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Chagas disease in Latin America: an epidemiological update based on 2010 estimates;Wkly Epidemiol Rec,2015

2. Global economic burden of Chagas disease: a computational simulation model;BY Lee;Lancet Infect Dis,2013

3. Chemotherapy of trypanosomiases and leishmaniasis;SL Croft;Trends Parasitol,2005

4. Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy;CA Morillo;N Engl J Med,2015

5. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection;JC Villar;Cochrane database Syst Rev,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipating the side effects of benznidazole: HLA-B*35 and patch test;Enfermedades infecciosas y microbiologia clinica (English ed.);2024-06

2. Alternative Approaches for the Treatment of Chagas Disease;ChemistrySelect;2024-05-06

3. Anticipating the side effects of benznidazole: HLA-B*35 and patch test;Enfermedades Infecciosas y Microbiología Clínica;2024-05

4. Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia;Transactions of The Royal Society of Tropical Medicine and Hygiene;2024-02-27

5. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy;International Immunopharmacology;2024-02